Product NDC: | 0527-1330 |
Proprietary Name: | Baclofen |
Non Proprietary Name: | baclofen |
Active Ingredient(s): | 10 mg/1 & nbsp; baclofen |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0527-1330 |
Labeler Name: | Lannett Company, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078220 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070701 |
Package NDC: | 0527-1330-10 |
Package Description: | 1000 TABLET in 1 BOTTLE, PLASTIC (0527-1330-10) |
NDC Code | 0527-1330-10 |
Proprietary Name | Baclofen |
Package Description | 1000 TABLET in 1 BOTTLE, PLASTIC (0527-1330-10) |
Product NDC | 0527-1330 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | baclofen |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20070701 |
Marketing Category Name | ANDA |
Labeler Name | Lannett Company, Inc. |
Substance Name | BACLOFEN |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | GABA A Agonists [MoA],GABA B Agonists [MoA],gamma-Aminobutyric Acid-ergic Agonist [EPC] |